Aletta Mutz is the Director of Clinical Trial Equipment & Supplies at Myoderm, a leading global clinical trial supply company. Her vast experience in managing global clinical supplies distribution, on both the sponsor and supplier side, makes her adept at providing unique supply solutions to clients. For over 15 years her strategic leadership has impacted life sciences companies like Wyeth and VWR. While working in Strategic Sourcing and Global Clinical Development for Wyeth, Aletta established their Global Clinical Logistics department. During her time with VWR she built their first clinical equipment and ancillary supplies service offering, managed their kitting services and supported the integration of several strategic clinical services acquisitions. Aletta has a BA in Foreign Affairs from the University of Virginia and an MBA from Drexel University.
Archives: Speakers
Amanda Paley
Amanda Paley is the Senior Director Clinical Development Strategy at AiCure and works with industry sponsors conducting phase I – IV studies. In her role Amanda works closely with sponsors to determine how to best align artificial intelligence technologies to support medication adherence, data quality, and collection of novel digital endpoints in their trials and enable new approaches to making data-driven decisions across their portfolio. Previously, she led the Enrollment Strategy and Protocol Analytics group at Acurian, where her team developed clinical trial patient recruitment strategies. She holds a psychology degree from Boston University and began her career in clinical research working as a study coordinator in multiple therapeutic areas at Boston University School of Medicine and the University of Texas Health Science Center.
Megan Liles
Dr. Christiana Hofmann
From my educational background I am biologist. I have completed my PhD at the Helmholtz Research Centre of Munich in cooperation with the Technical University of Munich in the field of toxicology.
After that I gained several years of experience in the pharmaceutical industry with a focus on quality management.
Since nearly 4 years, I am working within TÜV SÜD in the sector of Medical Health Services. Currently, I am leading a team of experts and auditors for non-active medical devices and I am responsible for the Article 117 business in the regions DACH & Nordics.
Besides these roles, I am Auditor and Senior Product Specialist for non-active medical devices.
Michael Wilkinson
Kenneth G. Faulkner
Dr Tobias Kruse
He is the founder and former CEO of Trials24, a company supporting biotech and pharmaceutical companies, as well as CROs, in accelerating patient recruitment. Trials24 was acquired by SubjectWell in September 2024 prior to its merger with Clariness.
Before founding Trials24, Tobias co-founded ImevaX, a biotech company focused on vaccine development, where he developed the entire digital patient recruitment strategy.
Tobias earned his PhD in Molecular Biotechnology from the Technical University of Munich, where he developed a vaccine against Helicobacter pylori. He holds numerous patents and has published papers in journals such as Nature and EMBO.
